Palisade Capital Management’s GW Pharmaceuticals Plc American Depositary Shares GWPH Stock Holding History

Palisade Capital Management’s Portfolio GWPH Stock Details GWPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-2,600	Closed	-$253K	–	414
2020 Q3	$253K	Buy	+2,600	New	+$299K	0.01%	366
2020 Q1	–	Sell	-2,750	Closed	-$288K	–	454
2019 Q4	$288K	Buy	+2,750	New	+$308K	0.01%	378

Other funds holding GWPH

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $155B AUM 29.93% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

EMG

ETF Managers Group Summit, New Jersey $3.1B AUM 17.12% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Palisade Capital Management's GWPH Position: Q4 2020 in Review

Palisade Capital Management sold out of GW Pharmaceuticals Plc American Depositary Shares (GWPH) in Q4 2020, closing a stake of 2,600 shares — an estimated $253K sold.

Palisade Capital Management first reported a position in GWPH in Q4 2019 and held it in 2 quarters. The position peaked at $288K in Q4 2019. 279 funds tracked by Wall St. Rank hold GWPH as of Q4 2020.

Palisade Capital Management reported no remaining GW Pharmaceuticals Plc American Depositary Shares position as of Q4 2020 after selling out during the quarter.
Palisade Capital Management sold 2,600 GW Pharmaceuticals Plc American Depositary Shares shares in Q4 2020, an estimated $253K.
Palisade Capital Management first reported a position in GW Pharmaceuticals Plc American Depositary Shares in Q4 2019 and held it in 2 quarters.
Palisade Capital Management's GW Pharmaceuticals Plc American Depositary Shares position peaked at $288K in Q4 2019.
279 funds tracked by Wall St. Rank held GW Pharmaceuticals Plc American Depositary Shares as of Q4 2020.

Based on Palisade Capital Management's 13F filing for Q4 2020, filed 11 Feb 2021.